FEOC
OFAC SDNCriticalEntity

QINSHENG PHARMACEUTICAL TECHNOLOGY CO., LTD.

🇨🇳ChinaCovered Nation26325

FEOC Flagged

QINSHENG PHARMACEUTICAL TECHNOLOGY CO., LTD. appears on 2 critical federal lists. Equipment, services, or transactions involving this entity likely fail FEOC requirements for IRA tax credits (45X, 48E, 30D).

Critical findings

  • OFAC SDN — Specially Designated Nationals list. Strict financial sanctions — U.S. persons are generally prohibited from dealing with these entities.
  • UFLPA Entity List — Entities using forced labor from Xinjiang. Goods are presumptively excluded from U.S. import per the Uyghur Forced Labor Prevention Act.

Covered nation: The IRA defines China, Russia, Iran, and North Korea as covered nations. Entities operating from these jurisdictions face heightened FEOC scrutiny independent of specific list designations.

Risk Summary
List severityHighOn 2 critical lists
Country riskHighChina (covered nation)
Ownership transparencyHighNot in global LEI registry — opacity flag
Parent exposureMediumNo parent data
Cross-list countMedium2 federal lists

Relationships at a glance

3 nodes · 2 relationships · open Network tab for full view
Federal list
OFAC SDN
Treasury OFAC
Federal list
UFLPA Entity List2026
DHS / FLETF
This entity
QINSHENG PHARMACEUTICAL TECHNOLOGY CO., LTD.Covered
China

Federal-list cross-reference

This entity name appears on 2 federal lists.

OFAC SDNTreasury OFAC

Specially Designated Nationals list. Strict financial sanctions — U.S. persons are generally prohibited from dealing with these entities.

Listed as: QINSHENG PHARMACEUTICAL TECHNOLOGY CO., LTD.#26325
Official list
UFLPA Entity ListDHS / FLETF

Entities using forced labor from Xinjiang. Goods are presumptively excluded from U.S. import per the Uyghur Forced Labor Prevention Act.

Listed as: Nanjing Lilai Pharmaceutical Technology Co., Ltd.Since 2026-08-03#Nanjing Lilai Pharmaceutical Technology Co., Ltd.
Official list

Relationship graph

3 nodes · 2 relationships
Federal list
OFAC SDN
Treasury OFAC
Federal list
UFLPA Entity List2026
DHS / FLETF
This entity
QINSHENG PHARMACEUTICAL TECHNOLOGY CO., LTD.Covered
China

Click any node to open its source. Federal lists at top, primary entity in center, parents and curated profile below.

Also known as

SHANGHAI QINSHENG PHARMACEUTICAL TECHNOLOGY CO., LTD.SHANGHAI QINSHENG PHARMACEUTICAL SCIENCE & TECHNOLOGY CO., LTD.SHANGHAI QINSHENG PHARMACEUTICAL SCIENCE AND TECHNOLOGY CO., LTD.

Known addresses

  • Room 614, Floor 3, No. 1, Alley 468, New Siping Highway, Shanghai 201413, China
  • Room 614, Floor 3, Block 1, Lane 468, Xinsiping Highway, Fengxian District, Shanghai, China

Sanctions programs / authorities

SDNTK

Sanctioning authority notes

Website www.qinvictory.com.

Data sources

  • OFAC SDN · Treasury OFACsource
  • UFLPA Entity List · DHS / FLETF · listed 2026-08-03source
Raw record (for audit / legal review)
{
  "source_list": "OFAC_SDN",
  "source_record_id": "26325",
  "source_url": "https://ofac.treasury.gov/specially-designated-nationals-list-data-formats-data-schemas",
  "citation": "Treasury OFAC SDN entry 26325",
  "entity_name": "QINSHENG PHARMACEUTICAL TECHNOLOGY CO., LTD.",
  "entity_type": "Entity",
  "country": "China",
  "aliases": [
    "SHANGHAI QINSHENG PHARMACEUTICAL TECHNOLOGY CO., LTD.",
    "SHANGHAI QINSHENG PHARMACEUTICAL SCIENCE & TECHNOLOGY CO., LTD.",
    "SHANGHAI QINSHENG PHARMACEUTICAL SCIENCE AND TECHNOLOGY CO., LTD."
  ],
  "addresses": [
    "Room 614, Floor 3, No. 1, Alley 468, New Siping Highway, Shanghai 201413, China",
    "Room 614, Floor 3, Block 1, Lane 468, Xinsiping Highway, Fengxian District, Shanghai, China"
  ],
  "programs": [
    "SDNTK"
  ],
  "date_added": null,
  "raw_data": {
    "grt": "-0- ",
    "title": "-0- ",
    "ent_num": "26325",
    "program": "SDNTK",
    "remarks": "Website www.qinvictory.com.",
    "tonnage": "-0- ",
    "sdn_name": "QINSHENG PHARMACEUTICAL TECHNOLOGY CO., LTD.",
    "sdn_type": "-0- ",
    "call_sign": "-0- ",
    "vess_flag": "-0- ",
    "vess_type": "-0- ",
    "vess_owner": "-0- "
  }
}

Informational only — not legal advice. Cross-list matching is name-based; verify identity with the source authority before procurement or compliance decisions.